These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25026028)

  • 21. Diminished expression of complement regulatory proteins (CD55 and CD59) in lymphocytes from systemic lupus erythematosus patients with lymphopenia.
    García-Valladares I; Atisha-Fregoso Y; Richaud-Patin Y; Jakez-Ocampo J; Soto-Vega E; Elías-López D; Carrillo-Maravilla E; Cabiedes J; Ruiz-Argüelles A; Llorente L
    Lupus; 2006; 15(9):600-5. PubMed ID: 17080916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human erythrocyte PIG-A assay: an easily monitored index of gene mutation requiring low volume blood samples.
    Dertinger SD; Avlasevich SL; Bemis JC; Chen Y; MacGregor JT
    Environ Mol Mutagen; 2015 May; 56(4):366-77. PubMed ID: 25412990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant EPO therapy increases erythrocyte expression of complement regulatory proteins.
    Ohi H; Tamano M; Sudo S; Okada N
    Am J Kidney Dis; 2003 Jan; 41(1):179-85. PubMed ID: 12500235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of complement regulatory proteins in diffuse proliferative glomerulonephritis.
    Arora M; Arora R; Tiwari SC; Das N; Srivastava LM
    Lupus; 2000; 9(2):127-31. PubMed ID: 10787010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement regulatory proteins in normal human esophagus and esophageal squamous cell carcinoma.
    Shimo K; Mizuno M; Nasu J; Hiraoka S; Makidono C; Okazaki H; Yamamoto K; Okada H; Fujita T; Shiratori Y
    J Gastroenterol Hepatol; 2004 Jun; 19(6):643-7. PubMed ID: 15151618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased expression of complement regulatory proteins, CD55 and CD59, on peripheral blood leucocytes in patients with type 2 diabetes and macrovascular diseases.
    Ma XW; Chang ZW; Qin MZ; Sun Y; Huang HL; He Y
    Chin Med J (Engl); 2009 Sep; 122(18):2123-8. PubMed ID: 19781296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical disease.
    Simpson KL; Jones A; Norman S; Holmes CH
    Am J Pathol; 1997 Nov; 151(5):1455-67. PubMed ID: 9358772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the effects of activation of the alternative pathway of complement on erythrocytes with an isolated deficiency of decay accelerating factor.
    Holguin MH; Martin CB; Bernshaw NJ; Parker CJ
    J Immunol; 1992 Jan; 148(2):498-502. PubMed ID: 1370313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The correlation of α-globin gene mutations and the XmnI polymorphism with clinical severity of Hb E/β-thalassemia.
    Charoenkwan P; Teerachaimahit P; Sanguansermsri T
    Hemoglobin; 2014; 38(5):335-8. PubMed ID: 25238043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of atorvastatin on the expression of CD55, CD59 in patients with hyperlipidemia].
    Liu YM; He JC; Yang JG; Liu YY; Yan X; Zhao L; Ma XW; Shang DY; Qiao CD; Li WX; Wang JY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Dec; 33(12):1075-9. PubMed ID: 16563273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. β- and α-Thalassemia intermedia in Basra, Southern Iraq.
    Abdulwahid DA; Hassan MK
    Hemoglobin; 2013; 37(6):553-63. PubMed ID: 23944608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenovirus-mediated expression of human CD55 or CD59 protects adult porcine islets from complement-mediated cell lysis by human serum.
    Schmidt P; Goto M; Le Mauff B; Anegon I; Korsgren O
    Transplantation; 2003 Mar; 75(5):697-702. PubMed ID: 12640312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membrane-bound regulators of complement activation in uveal melanomas. CD46, CD55, and CD59 in uveal melanomas.
    Goslings WR; Blom DJ; de Waard-Siebinga I; van Beelen E; Claas FH; Jager MJ; Gorter A
    Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1884-91. PubMed ID: 8759358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of paroxysmal nocturnal hemoglobinuria in Chinese patients with Budd-Chiari syndrome or portal vein thrombosis.
    Qi X; He C; Han G; Yin Z; Wu F; Zhang Q; Niu J; Wu K; Fan D
    J Gastroenterol Hepatol; 2013 Jan; 28(1):148-52. PubMed ID: 23020629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biophysical characterization of beta-thalassemic red blood cells.
    Desouky OS; Selim NS; El-Bakrawy EM; El-Marakby SM
    Cell Biochem Biophys; 2009; 55(1):45-53. PubMed ID: 19585085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.
    Brasoveanu LI; Altomonte M; Fonsatti E; Colizzi F; Coral S; Nicotra MR; Cattarossi I; Cattelan A; Natali PG; Maio M
    Lab Invest; 1996 Jan; 74(1):33-42. PubMed ID: 8569195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization against tumor cell surface complement-regulatory proteins.
    Durrant LG; Spendlove I
    Curr Opin Investig Drugs; 2001 Jul; 2(7):959-66. PubMed ID: 11757799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of glycosylphosphatidylinositol specific phospholipase D gene expression levels on complement mediated killing of leukemic cells in patients with chronic myeloid leukemia.
    Jian-Hua T; Xiao-Jie Z; Yi-Dan W; Wen-Kai L; Wang-Jiao H; Cheng-Hong W; Gui-Yuan L
    Clin Chim Acta; 2005 Sep; 359(1-2):115-24. PubMed ID: 15907827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of changes in CD20, CD55, and CD59 expression on established rituximab-resistant B-lymphoma cell lines.
    Takei K; Yamazaki T; Sawada U; Ishizuka H; Aizawa S
    Leuk Res; 2006 May; 30(5):625-31. PubMed ID: 16289746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Etiopathological mechanisms and clinical characteristics of hyperhemolysis syndrome in Spanish patients with thalassemia.
    Vagace JM; Cardesa R; Corbacho A; Vázquez T; de la Maya MD; Gonzalez FA; Nieto JB; Urrutia E; Gómez MJ; Pascual T; Aguinaco MR; Gervasini G
    Ann Hematol; 2016 Sep; 95(9):1419-27. PubMed ID: 27392662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.